These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
The new facility marks Align’s first manufacturing presence in India and its fourth globally
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
A one-shot gene-editing cholesterol therapy could soon be a reality
The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
Clearance marks major shift beyond chemotherapy
Subscribe To Our Newsletter & Stay Updated
